LMR Partners’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.55M Hold
800,000
0.03% 469
2026
Q1
$8.46M Hold
800,000
0.02% 478
2025
Q4
$8.39M Hold
800,000
0.02% 434
2025
Q3
$8.28M Hold
800,000
0.04% 381
2025
Q2
$8.22M Hold
800,000
0.06% 326
2025
Q1
$8.06M Buy
+800,000
New +$8.04M 0.08% 296

Other funds holding TDAC

LMR Partners's TDAC Position: Q2 2026 in Review

LMR Partners held its Translational Development Acquisition Corp (TDAC) position steady in Q2 2026 at 800,000 shares worth $8.55M. The position accounts for 0.03% of the portfolio, ranked #469.

LMR Partners first reported a position in TDAC in Q1 2025 and has held it in 6 quarters since. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • LMR Partners held 800,000 shares of Translational Development Acquisition Corp worth $8.55M as of Q2 2026.
  • LMR Partners left its Translational Development Acquisition Corp share count unchanged in Q2 2026.
  • Translational Development Acquisition Corp made up 0.03% of LMR Partners's portfolio in Q2 2026, its #469 holding.
  • LMR Partners first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.